Artificial Intelligence for Clinical Decision Support in Acute Ischemic Stroke: A Systematic Review.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
06 2023
Historique:
medline: 24 5 2023
pubmed: 22 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

Established randomized trial-based parameters for acute ischemic stroke group patients into generic treatment groups, leading to attempts using various artificial intelligence (AI) methods to directly correlate patient characteristics to outcomes and thereby provide decision support to stroke clinicians. We review AI-based clinical decision support systems in the development stage, specifically regarding methodological robustness and constraints for clinical implementation. Our systematic review included full-text English language publications proposing a clinical decision support system using AI techniques for direct decision support in acute ischemic stroke cases in adult patients. We (1) describe data and outcomes used in those systems, (2) estimate the systems' benefits compared with traditional stroke diagnosis and treatment, and (3) reported concordance with reporting standards for AI in healthcare. One hundred twenty-one studies met our inclusion criteria. Sixty-five were included for full extraction. In our sample, utilized data sources, methods, and reporting practices were highly heterogeneous. Our results suggest significant validity threats, dissonance in reporting practices, and challenges to clinical translation. We outline practical recommendations for the successful implementation of AI research in acute ischemic stroke treatment and diagnosis.

Sections du résumé

BACKGROUND
Established randomized trial-based parameters for acute ischemic stroke group patients into generic treatment groups, leading to attempts using various artificial intelligence (AI) methods to directly correlate patient characteristics to outcomes and thereby provide decision support to stroke clinicians. We review AI-based clinical decision support systems in the development stage, specifically regarding methodological robustness and constraints for clinical implementation.
METHODS
Our systematic review included full-text English language publications proposing a clinical decision support system using AI techniques for direct decision support in acute ischemic stroke cases in adult patients. We (1) describe data and outcomes used in those systems, (2) estimate the systems' benefits compared with traditional stroke diagnosis and treatment, and (3) reported concordance with reporting standards for AI in healthcare.
RESULTS
One hundred twenty-one studies met our inclusion criteria. Sixty-five were included for full extraction. In our sample, utilized data sources, methods, and reporting practices were highly heterogeneous.
CONCLUSIONS
Our results suggest significant validity threats, dissonance in reporting practices, and challenges to clinical translation. We outline practical recommendations for the successful implementation of AI research in acute ischemic stroke treatment and diagnosis.

Identifiants

pubmed: 37216446
doi: 10.1161/STROKEAHA.122.041442
doi:

Types de publication

Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1505-1516

Commentaires et corrections

Type : CommentIn

Auteurs

Ela Marie Z Akay (EMZ)

Charité Lab for Artificial Intelligence in Medicine (CLAIM) (E.M.Z.A., A.H., D.F.), Charité Universitätsmedizin Berlin, Germany.

Adam Hilbert (A)

Charité Lab for Artificial Intelligence in Medicine (CLAIM) (E.M.Z.A., A.H., D.F.), Charité Universitätsmedizin Berlin, Germany.

Benjamin G Carlisle (BG)

QUEST Center for Responsible Research, Berlin Institute of Health (BIH) (B.G.C., V.I.M.), Charité Universitätsmedizin Berlin, Germany.

Vince I Madai (VI)

QUEST Center for Responsible Research, Berlin Institute of Health (BIH) (B.G.C., V.I.M.), Charité Universitätsmedizin Berlin, Germany.
Faculty of Computing, Engineering and the Built Environment, School of Computing and Digital Technology, Birmingham City University, United Kingdom (V.I.M.).

Matthias A Mutke (MA)

Department of Neuroradiology, Heidelberg University Hospital, Germany (M.A.M.).

Dietmar Frey (D)

Charité Lab for Artificial Intelligence in Medicine (CLAIM) (E.M.Z.A., A.H., D.F.), Charité Universitätsmedizin Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH